Cell Met: COVID-19 Has a poor prognosis! Maybe it's because blood sugar control is poor!

15 May 2020, News /BiovalleyBIOON / - This study highlights: 7337 cases of a diabetes embodiment COVID-19 a patients and non-diabetic patientsretrospective study; during COVID-19,a diabetic condition increases the need for medical intervention;diabetes
state increased the risk of death in patients with COVID-19; good blood glucose control and improve the prognosis of patients with infection-relatedA type 2 diabetes (of T2D) COVID-19 is a major complicationHowever, blood glucose (BG) control is still uncertain impact COVID-19 and T2D patients required medical intervention and the degree of mortality rightSource: CellMetablismTherefore, the research team from Wuhan University, Li Hongliang led to 7337 cases COVID 19-patient multicenter, Hubei Province, China conducted a retrospective study, 952 cases in which the presence of T2DThe researchers found that compared with non-diabetic patients, T2D patients need more medical intervention, mortality was significantly higher (7.8% more than 2.7%; adjusted hazard ratio [HR], 1.49), a greater degree of multiple organ damageaddition, researchers also found that, compared with patients with poor blood glucose control (blood glucose change exceeding the upper limit 10.0mmol / L), patients with good glycemic control (blood glucose varied from 3.9 to 10.0mmol / L between) significantly lower mortality during hospitalization (HR adjusted 0.14)Overall, these findings provide improved 19 COVID-patient has clinical evidence of T2D and glycemic control and improved prognosisa (Biovalley Bioon.com) References:HongliangLietalAssociationofBloodGlucoseControlandOutcomesinPatientswithCOVID-19andPre-existingType2Diabetes .CellMetablism.2020.DOI: https: //doi.org/10.1016/ j.cmet.2020.04.021